suzetrigine fda - Search News

FDA approves new pain medicine

USA TODAY on MSN · 3d

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Time on MSN · 13h

FDA Approves the First Non-Opioid Pain Medicine in 20 Years

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non-opioid painkiller since that class first appeared on the market in the 1980s.

The American Journal of Manage… · 3d

Suzetrigine: First-in-Class Nonopioid Pain Therapy Is Approved by FDA

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as a selective NaV1.8 pain signal inhibitor, an alternative to opiates.

3d

Historic FDA approval marks first nonopioid breakthrough since Clinton era

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...

3d

FDA approves first non-opioid pain medicine in more than 20 years

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results